Kenneth Oh

Kelly King

Brad VanderWielen

Candice Cox

Presented by:

Kenneth Oh, PhD, Collaborations, Applications, and New Technology Senior Global Manager

Kelly King, PhD, Field Application Specialist II

Brad VanderWielen, PhD, Field Application Specialist II

Candice Cox, Global Marketing Manager, Immunoassays

Date: February 9, 2021
Time: 9 AM, U.S. Pacific time

Several publications have reported the varying duration of acquired immunity to SARS-CoV-2. We will review these reports and discuss numerous factors that contribute to the longevity and duration of such immunity by discussing some of the underlying mechanisms of the adaptive immune response, including lymphocyte activity, cytokine and chemokine activity, as well as the effects of preexisting conditions and immune history. Additionally, we will investigate the relationship between symptom severity and the longevity of acquired immunity.

You will learn about:

  • SARS‑CoV‑2 virion and ACE2 binding
  • Initiation of the adaptive response
  • T‑ and B‑lymphocyte maturity
  • B‑lymphocyte conversion to memory and plasma cells
  • Factors that affect the duration of acquired immunity
Watch Webinar
Previous post

Automate Your Antibody Purification Workflow at Preparative and Analytical Scale

Next post

The Role of ddPCR in Developing Safe and Effective AAV-Based Gene Therapies